This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove Clinical Supply Remove Marketing Remove Reagent Related Topics
Genetic Engineering Protein Packaging Genomics Genome Gene Therapy FDA Approval Genetics Antibody Gene More Related Topics >
article thumbnail

IN FOCUS: Syngene International

Pharmaceutical Technology

APRIL 28, 2023

Its scope includes Syngene providing integrated drug discovery and development solutions in discovery chemistry and biology, peptide chemistry, antibody and protein reagents, pharmacokinetics and drug metabolism, and pharmaceutical development. until 2026. Syngene’s collaboration with Zoetis started in 2011.

Manufacturing 130
Manufacturing Antibody Clinical Supply Protein 130
article thumbnail

Overcoming inefficiencies to improve access to cell and gene therapy 

Drug Discovery World

MARCH 13, 2023

Between the 24 therapies already approved by the FDA 1 and a marked increase in clinical trials, widespread accessibility to precision medicine feels within reach. The individual successes within the CGT market are impressive, but this therapeutic class remains unattainable to the vast majority of the world.

Gene Therapy 52
Gene Therapy Gene Manufacturing Development 52
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 32,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024